Clinical features and genome-wide copy number variation analysis in 60 children with early-onset epileptic encephalopathies of unknown cause
MA Yu-Ping, PENG Jing, WANG Ying, CHEN Yun, WU Li-Wen, YIN Fei
Department of Pediatrics, Xiangya Hospital of Central South University/Hunan Intellectual and Developmental Disabilities Research Center, Changsha 410008, China
Abstract：Objective To study the clinical features of early-onset epileptic encephalopathies (EEEs) of unknowncause, and to identify pathogenic microdeletion/microduplication of EEEs by genome-wide analysis of copy numbervariations (CNVs). Methods The clinical data of 60 children diagnosed with unexplained EEEs between July 2012 and April 2013 were obtained and analyzed. Specimens were collected from the selected children and their parents.Single nucleotide polymorphism array was used to detect genome-wide CNVs, and fluorescence in situ hybridizationwas performed to verify the results and analyze the source of the parents, further to identify suspected pathogenic CNVsof EEEs. Results Among the 60 children with unexplained EEEs, 34 were diagnosed with West syndrome, 3 withOhtahara syndrome, 3 with Dravet syndrome, and 20 with unclassified EEEs. In total, 77% of the patients were associatedwith moderate to severe mental retardation. Head imaging test implied that 35% of the patients had brain dysplasiaor astrophy. Among 54 patients, 17% showed microcephalus. After treatment, 28 patients had clinical seizures undercontrol, 16 out of control, 5 dead, and 1 lost to follow-up. Genome-wide analysis of CNVs showed that 7 pathogenic orsuspected pathogenic CNVs were present in 5 patients. Conclusions EEEs of unknown cause are associated with highphenotypic heterogeneity and poor prognosis. Genome-wide CNVs analysis can demonstrate pathogenic or suspectedpathogenic CNVs. This research expands the gene bank of EEEs and improves the understanding about possible etiologyof unexplained EEEs. The results provide a reference for genetic counseling regarding reproduction in the patient'sfamily.
MA Yu-Ping,PENG Jing,WANG Ying et al. Clinical features and genome-wide copy number variation analysis in 60 children with early-onset epileptic encephalopathies of unknown cause[J]. CJCP, 2014, 16(11): 1100-1104.
Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies:Report of the ILAE Commission on Classification and Terminology, 2005-2009[J]. Epilepsia, 2010, 51(4):676-685.
[2]
Feuk L, Carson AR, Scherer SW. Structural variation in the human genome[J]. Nat Rev Genet, 2006, 7(2):85-97.
[3]
Mefford HC, Eichler EE. Duplication hotspots, rare genomic disorders, and common disease[J]. Curr Opin Genet Dev, 2009, 19(3):196-204.
[4]
Helbig I, Mefford HC, Sharp AJ, et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy [J]. Nat Genet, 2009, 41(2):160-162.
[5]
De Kovel CG, Trucks H, Helbig I, et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies[J]. Brain, 2010, 133(Pt 1):23-32.
[6]
Mefford HC, Yendle SC, Hsu C, et al. Rare copy number variants are an important cause of epileptic encephalopathies [J]. Ann Neurol, 2011, 70(6):974-985.
[7]
Bedoyan JK, Kumar RA, Sudi J, et al. Duplication 16p11.2 in a child with infantile seizure disorder[J]. Am J Med Genet A, 2010, 152A(6):1567-1574.
Ballif BC1, Rosenfeld JA, Traylor R, et al. High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44[J]. Hum Genet, 2012, 131(1):145-156.
[11]
Claes L, Del-Favero J, Ceulemans B, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy[J]. Am J Hum Genet, 2001, 68(6):1327-1332.
[12]
Depienne C, Trouillard O, Saint-Martin C, et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome:analysis of 333 patients[J]. Med Genet, 2009, 46(3):183-191.
[13]
Singh NA, Pappas C, Dahle EJ, et al. A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome[J]. PLoS Genet, 2009, 5(9):e1000649.
[14]
Gorter JA, Zurolo E, Iyer A, et al. Induction of sodium channel Na(x) (SCN7A) expression in rat and human hippocampus in temporal lobe epilepsy[J]. Aronica E Epilepsia, 2010, 51(9):1791-1800.
[15]
Chioza BA, Aicardi J, Aschauer H, et al. Genome wide high density SNP-based linkage analysis of childhood absence epilepsy identifies a susceptibility locus on chromosome 3p23-p14[J]. Epilepsy Res, 2009, 87(2-3):247-255.
[16]
Covanis A. Epileptic encephalopathies(including severe epilepsy syndromes) [J]. Epilepsia, 2012, 53(Suppl 4):114-126.
